loading...

LYMPH-Q© (LYMPH-Q©)

Klassen AF; Mehrara B; Dayan J; Vasilic D; Jørgensen MG; Jacobsen AL; Beelen LM; Kaur MN; Tsangaris E; Poulsen L; Sørensen JA; Pusic AL

ProQolid

Last update: November 2021

Basic description

  • Published in 2021
Authors

Klassen AF; Mehrara B; Dayan J; Vasilic D; Jørgensen MG; Jacobsen AL; Beelen LM; Kaur MN; Tsangaris E; Poulsen L; Sørensen JA; Pusic AL

Copyright
Copyright © Memorial Sloan Kettering Cancer Center (New York City, USA), Brigham and Women’s Hospital (Boston, USA), and McMaster University (Hamilton, Canada). All rights reserved
Objective
To measure arm lymphedema in women with breast cancer
Therapeutic area
  • Hemic and Lymphatic Diseases
Therapeutic indication

Lymphedema

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
Translations
3 translation(s)
Bibliographic reference(s) of the original questionnaire

Klassen AF, Tsangaris E, Kaur MN, Poulsen L, Beelen LM, Jacobsen AL, Jørgensen MG, Sørensen JA, Vasilic D, Dayan J, Mehrara B, Pusic AL. Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: The LYMPH-Q Upper Extremity Module. Ann Surg Oncol. 2021 Sep;28(9):5166-5182 (Full text article)